Patents by Inventor David Edward Ormonde Knight

David Edward Ormonde Knight has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TAU-BINDING ANTIBODIES
    Publication number: 20230416350
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Application
    Filed: June 30, 2023
    Publication date: December 28, 2023
    Inventors: DAVID EDWARD ORMONDE KNIGHT, TERENCE SEWARD BAKER, DAVID JAMES MCMILLAN, ROBERT ANTHONY GRIFFIN, GEORGES MAIRET-COELLO, PATRICK DOWNEY, JEAN-PHILIPPE COURADE
  • TAU-BINDING ANTIBODIES
    Publication number: 20230331833
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Application
    Filed: June 30, 2023
    Publication date: October 19, 2023
    Inventors: KERRY LOUISE TYSON, TERENCE SEWARD BAKER, GEORGES MAIRET-COELLO, PATRICK DOWNEY, JEAN-PHILIPPE COURADE, DAVID EDWARD ORMONDE KNIGHT
  • Tau-binding antibodies
    Patent number: 11746145
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Grant
    Filed: December 29, 2020
    Date of Patent: September 5, 2023
    Assignee: UCB BIOPHARMA SRL
    Inventors: Kerry Louise Tyson, Terence Seward Baker, Georges Mairet-Coello, Patrick Downey, Jean-Philippe Courade, David Edward Ormonde Knight
  • Tau-binding antibodies
    Patent number: 11732034
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Grant
    Filed: December 29, 2020
    Date of Patent: August 22, 2023
    Assignee: UCB BIOPHARMA SRL
    Inventors: David Edward Ormonde Knight, Terence Seward Baker, David James McMillan, Robert Anthony Griffin, Georges Mairet-Coello, Patrick Downey, Jean-Philippe Courade
  • TAU-BINDING ANTIBODIES
    Publication number: 20210139574
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Application
    Filed: December 29, 2020
    Publication date: May 13, 2021
    Inventors: KERRY LOUISE TYSON, TERENCE SEWARD BAKER, GEORGES MAIRET-COELLO, PATRICK DOWNEY, JEAN-PHILIPPE COURADE, DAVID EDWARD ORMONDE KNIGHT
  • TAU-BINDING ANTIBODIES
    Publication number: 20210115121
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Application
    Filed: December 29, 2020
    Publication date: April 22, 2021
    Inventors: DAVID EDWARD ORMONDE KNIGHT, TERENCE SEWARD BAKER, DAVID JAMES MCMILLAN, ROBERT ANTHONY GRIFFIN, GEORGES MAIRET-COELLO, PATRICK DOWNEY, JEAN-PHILIPPE COURADE
  • Tau-binding antibodies
    Patent number: 10906966
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: February 2, 2021
    Assignee: UCB BIOPHARMA SRL
    Inventors: Kerry Louise Tyson, Terence Seward Baker, Georges Mairet-Coello, Patrick Downey, Jean-Philippe Courade, David Edward Ormonde Knight
  • Tau-binding antibodies
    Patent number: 10889640
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Grant
    Filed: May 13, 2019
    Date of Patent: January 12, 2021
    Assignee: UCB BIOPHARMA SPRL
    Inventors: David Edward Ormonde Knight, Terence Seward Baker, David James McMillan, Robert Anthony Griffin, Georges Mairet-Coello, Patrick Downey, Jean-Philippe Courade
  • NEUTRALISING ANTIBODIES TO THE MAJOR EXOTOXINS TCDA AND TCDB OF CLOSTRIDIUM DIFFICILE
    Publication number: 20200377578
    Abstract: This present invention describes the derivation and selection of antibodies capable of neutralising the major exotoxins; TcdA and TcdB of Clostridium difficile. The invention also describes novel neutralisation and antigen binding properties of individual Mabs and mixtures thereof.
    Type: Application
    Filed: July 2, 2020
    Publication date: December 3, 2020
    Applicant: UCB Biopharma SPRL
    Inventors: David Paul Humphreys, Daniel John Lightwood, Kerry Louise Tyson, David Edward Ormonde Knight, Karine Jeannine Madeleine Hervé, Joanne Elizabeth Compson, Matthew Jon Timothy Page, Andrew Charles Payne, Nicola Louise Fisher, Brendon MacKenzie, Matthew Cox
  • Neutralising antibodies to the major exotoxins TCDA and TCDB of
    Patent number: 10752676
    Abstract: This present invention describes the derivation and selection of antibodies capable of neutralising the major exotoxins; TcdA and TcdB of Clostridium difficile. The invention also describes novel neutralisation and antigen binding properties of individual Mabs and mixtures thereof.
    Type: Grant
    Filed: September 10, 2012
    Date of Patent: August 25, 2020
    Assignee: UCB Biopharma SPRL
    Inventors: David Paul Humphreys, Daniel John Lightwood, Kerry Louise Tyson, David Edward Ormonde Knight, Karine Jeannine Madeleine Hervé, Joanne Elizabeth Compson, Matthew Jon Timothy Page, Andrew Charles Payne, Nicola Louise Fisher, Brendon Mackenzie, Matthew Cox
  • TAU-BINDING ANTIBODIES
    Publication number: 20190375829
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Application
    Filed: July 1, 2019
    Publication date: December 12, 2019
    Inventors: KERRY LOUISE TYSON, TERENCE SEWARD BAKER, GEORGES MAIRET-COELLO, PATRICK DOWNEY, JEAN-PHILIPPE COURADE, DAVID EDWARD ORMONDE KNIGHT
  • TAU-BINDING ANTIBODIES
    Publication number: 20190284267
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Application
    Filed: May 13, 2019
    Publication date: September 19, 2019
    Inventors: DAVID EDWARD ORMONDE KNIGHT, TERENCE SEWARD BAKER, DAVID JAMES MCMILLAN, ROBERT ANTHONY GRIFFIN, GEORGES MAIRET-COELLO, PATRICK DOWNEY, JEAN-PHILIPPE COURADE
  • Tau-binding antibodies
    Patent number: 10344081
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Grant
    Filed: July 5, 2016
    Date of Patent: July 9, 2019
    Assignee: UCB BIOPHARMA SPRL
    Inventors: Kerry Louise Tyson, Terence Seward Baker, Georges Mairet-Coello, Patrick Downey, Jean-Philippe Courade, David Edward Ormonde Knight
  • Tau-binding antibodies
    Patent number: 10287343
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Grant
    Filed: July 5, 2016
    Date of Patent: May 14, 2019
    Assignee: UCB BIOPHARMA SPRL
    Inventors: David Edward Ormonde Knight, Terence Seward Baker, David James McMillan, Robert Anthony Griffin, Georges Mairet-Coello, Patrick Downey, Jean-Philippe Courade
  • TAU-BINDING ANTIBODIES
    Publication number: 20180201666
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Application
    Filed: July 5, 2016
    Publication date: July 19, 2018
    Inventors: DAVID EDWARD ORMONDE KNIGHT, TERENCE SEWARD BAKER, DAVID JAMES MCMILLAN, ROBERT ANTHONY GRIFFIN, GEORGES MAIRET-COELLO, PATRICK DOWNEY, JEAN-PHILIPPE COURADE
  • TAU-BINDING ANTIBODIES
    Publication number: 20180194832
    Abstract: The present invention relates to Tau-binding antibodies and binding fragments thereof.
    Type: Application
    Filed: July 5, 2016
    Publication date: July 12, 2018
    Inventors: Kerry Louise TYSON, Terence Seward BAKER, Georges MAIRET-COELLO, Patrick DOWNEY, Jean-Philippe COURADE, David Edward Ormonde KNIGHT
  • NEUTRALISING ANTIBODIES TO THE MAJOR EXOTOXINS TCDA AND TCDB OF CLOSTRIDIUM DIFFICILE
    Publication number: 20140348844
    Abstract: This present invention describes the derivation and selection of antibodies capable of neutralising the major exotoxins; TcdA and TcdB of Clostridium difficile. The invention also describes novel neutralisation and antigen binding properties of individual Mabs and mixtures thereof.
    Type: Application
    Filed: September 10, 2012
    Publication date: November 27, 2014
    Applicant: UCB PHARMA S.A.
    Inventors: David Paul Humphreys, Daniel John Lightwood, Kerry Louise Tyson, David Edward Ormonde Knight, Karine Jeannine Madeleine Hervé, Joanne Elizabeth Compson, Matthew Jon Timothy Page, Andrew Charles Payne, Nicola Louise Fisher, Brendon Mackenze, Matthew Cox